Difference between revisions of "Category:Malignant solid neoplasm, MSI-H or dMMR medications"
Jump to navigation
Jump to search
(Created page with "Medications with some degree of efficacy in the treatment of microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) tumors, regardless of anatomic site of...") |
m |
||
Line 1: | Line 1: | ||
− | Medications with some degree of efficacy in the treatment of microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) tumors, regardless of anatomic site of origin. | + | Medications with some degree of efficacy in the treatment of [[MSI-H or dMMR|microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) tumors]], regardless of anatomic site of origin. |
[[Category:Site-agnostic medications]] | [[Category:Site-agnostic medications]] |
Revision as of 20:31, 26 April 2018
Medications with some degree of efficacy in the treatment of microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) tumors, regardless of anatomic site of origin.
Pages in category "Malignant solid neoplasm, MSI-H or dMMR medications"
The following 5 pages are in this category, out of 5 total.